Evidence map›Paper›PMID 31689890›Full record

Trial reportNutrients2019

The Effects of Iodine Supplementation in Pregnancy on Iodine Status, Thyroglobulin Levels and Thyroid Function Parameters: Results from a Randomized Controlled Clinical Trial in a Mild-to-Moderate Iodine Deficiency Area.

Simona Censi, Sara Watutantrige-Fernando, Giulia Groccia, Jacopo Manso, Mario Plebani, Diego Faggian, Monica Maria Mion, Roberta Venturini, Alessandra Andrisani, Anna Casaro and 7 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Iodine Supplementation Before, During and After Pregnancy.Geburtshilfe und Frauenheilkunde · 2026
    Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Simona CensiDepartment of Medicine (DIMED), Endocrinology Unit; University of Padova, 35121 Padova, Italy. simona.censi@phd.unipd.it.ORCID 0000-0001-6946-9673
Sara Watutantrige-FernandoDepartment of Medicine (DIMED), Endocrinology Unit; University of Padova, 35121 Padova, Italy. sara.watutantrige@gmail.com.
Giulia GrocciaDepartment of Medicine (DIMED), Endocrinology Unit; University of Padova, 35121 Padova, Italy. giulia.groccia@gmail.com.
Jacopo MansoDepartment of Medicine (DIMED), Endocrinology Unit; University of Padova, 35121 Padova, Italy. jacopo.manso@gmail.com.
Mario PlebaniLaboratory Medicine, Department of Medical and Surgical Sciences, University of Padua, 35121 Padua, Italy. mario.plebani@unipd.it.
Diego FaggianLaboratory Medicine, Department of Medical and Surgical Sciences, University of Padua, 35121 Padua, Italy. diego.faggian@aopd.veneto.it.
Monica Maria MionLaboratory Medicine, Department of Medical and Surgical Sciences, University of Padua, 35121 Padua, Italy. monica.mion@aopd.veneto.it.
Roberta VenturiniLaboratory Medicine, Department of Medical and Surgical Sciences, University of Padua, 35121 Padua, Italy. roberta.venturini@aopd.veneto.it.
Alessandra AndrisaniDepartment of Women's and Children's Health, University of Padua, Salus Pueri, 35128 Padua, Italy. alessandra.andrisani@unipd.it.
Anna CasaroDepartment of Medicine (DIMED), Endocrinology Unit; University of Padova, 35121 Padova, Italy. anna.casaro@aulss6.veneto.it.
Pietro VitaDepartment of Medicine (DIMED), Endocrinology Unit; University of Padova, 35121 Padova, Italy. pietro.vida@aulss6.veneto.it.
Alessandra AvogadroDepartment of Medicine (DIMED), Endocrinology Unit; University of Padova, 35121 Padova, Italy. alessandra.avogadro@aulss6.veneto.it.
Marta CamilotDepartment of Pediatrics, Regional Centre for Newborn Screening, Diagnosis and Treatment of Inherited Metabolic Diseases and Congenital Endocrine Diseases, Azienda Ospedaliera Universitaria Integrata, 37134 Verona, Italy. marta.camilot@aovr.veneto.it.
Carla ScaroniDepartment of Medicine (DIMED), Endocrinology Unit; University of Padova, 35121 Padova, Italy. carla.scaroni@unipd.it.
Loris BertazzaDepartment of Medicine (DIMED), Endocrinology Unit; University of Padova, 35121 Padova, Italy. loris.bertazza@unipd.it.ORCID 0000-0001-7931-0084
Susi BarolloDepartment of Medicine (DIMED), Endocrinology Unit; University of Padova, 35121 Padova, Italy. susibarollo@yahoo.it.ORCID 0000-0002-5821-2693
Caterina MianDepartment of Medicine (DIMED), Endocrinology Unit; University of Padova, 35121 Padova, Italy. caterina.mian@unipd.it.ORCID 0000-0003-2615-8001
University of Padua · ITAzienda Ospedaliera Universitaria Integrata Verona · IT

Funding

undefined <span style="color:gray;font-size:10px;">undefined</span> 0035273
6 · The paper itself

Abstract

backgroundIodine supplementation during pregnancy in areas with mild-to-moderate iodine deficiency is still debated.

methodsA single-center, randomized, single-blind and placebo-controlled (3:2) trial was conducted. We enrolled 90 women before 12 weeks of gestation. From enrollment up until 8 weeks after delivery, 52 women were given an iodine supplement (225 ug/day, potassium iodide tablets) and 38 were given placebo. At recruitment (T0), in the second (T1) and third trimesters (T2), and 8 weeks after delivery (T3), we measured participants' urinary iodine-to-creatinine ratio (UI/Creat), thyroid function parameters (thyroglobulin (Tg), TSH, FT3, and FT4), and thyroid volume (TV). The newborns' urinary iodine concentrations were evaluated in 16 cases.

resultsMedian UI/Creat at recruitment was 53.3 ug/g. UI/Creat was significantly higher in supplemented women at T1 and T2. Tg levels were lower at T1 and T2 in women with UI/Creat ≥ 150 ug/g, and in the Iodine group at T2 (

conclusionTg proved a good parameter for measuring iodine intake in our placebo-controlled series. Iodine supplementation did not prove harmful to pregnancy in areas of mild-to-moderate iodine deficiency, with no appreciable harmful effect on thyroid function.

Indexed as

Thyroid Function TestsAdultDietary SupplementsFemaleHumansInfant, NewbornIodinePregnancyPregnancy ComplicationsThyroglobulinThyroid GlandThyroxineTrace ElementsIodineThyroglobulinThyroxineTrace Elementsiodinemild-to-moderate iodine deficiencypregnancyrandomized and placebo-controlled trial

Identifiers

PMID31689890
PMCPMC6893432
OpenAlexW2986483006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.